BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20132919)

  • 21. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD; Tang M; Lager KM
    Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
    Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
    Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
    Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
    Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States.
    Vincent AL; Lager KM; Ma W; Lekcharoensuk P; Gramer MR; Loiacono C; Richt JA
    Vet Microbiol; 2006 Dec; 118(3-4):212-22. PubMed ID: 16962262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.
    Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
    Vaccine; 2012 Apr; 30(20):3119-25. PubMed ID: 22391400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
    Pushko P; Kort T; Nathan M; Pearce MB; Smith G; Tumpey TM
    Vaccine; 2010 Jul; 28(30):4771-6. PubMed ID: 20470801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.
    Ferrari M; Borghetti P; Foni E; Robotti C; Di Lecce R; Corradi A; Petrini S; Bottarelli E
    Zoonoses Public Health; 2010 Jun; 57(4):273-80. PubMed ID: 19538454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.
    Furuya Y; Regner M; Lobigs M; Koskinen A; Müllbacher A; Alsharifi M
    J Gen Virol; 2010 Jun; 91(Pt 6):1450-60. PubMed ID: 20147516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
    Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
    Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
    J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Henningson JN; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vet Pathol; 2012 Nov; 49(6):900-12. PubMed ID: 22461226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Sui J; Yang D; Qiao C; Xu H; Xu B; Wu Y; Yang H; Chen Y; Chen H
    Vaccine; 2016 Jul; 34(33):3757-63. PubMed ID: 27321744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
    Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
    Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.